The first documented outbreak of systemic candidosis shown to be due to cross infection with a particular strain of Candida albicans is reported. Over nine months in an intensive care unit 13 patients developed definite and one probable systemic candidosis. Twenty five further patients had superficial candidal infections. The strain that caused the outbreak (serotype A, morphotype
Introduction
The incidence of systemic candidosis is increasing, and this trend is likely to continue as the population of susceptible patients increases.' Mortality is high (75%) despite treatment with amphotericin B, which is nephrotoxic.' Chemoprophylaxis with oral antifungal agents is therefore being used increasingly in patients at high risk of infection, as the gastrointestinal tract is regarded as the major source of invasive candidosis.3 High dosages of oral nystatin, amphotericin B, or ketoconazole reduce colonisation and may decrease the incidence of invasive candidosis in neutropenic patients. No form of chemoprophylaxis, however, is completely satisfactory.4 -6 The development of invasive candidosis is usually attributed to autoinfection by yeasts colonising the patient's bowel or intravenous catheters.7 -9 A recent outbreak of systemic infection with Candida parapsilosis, however, was due to exogenous infection from contaminated intravenous feeds. ' the study were grouped according to their length of stay in the unit. The prevalence of the outbreak strain among patients who spent less than three days in the unit was 085% (2/235 patients), compared with 54% (32/59) among those who stayed in the unit for more than three days. Among this second group, the 27 patients who never carried the outbreak strain spent an average of 8-6 days in the unit (total 233 days) whereas the 32 patients who did acquire the outbreak strain spent an average of 21 days in the unit (total 673 days). Thus there was a higher risk of colonisation by the outbreak strain for patients who remained in the unit for a long time. The average time between admission to the unit and colonisation with the outbreak strain was 6-6 days. This was consistent with a model of superinfection with an exogenous candidal strain. Four of the patients who subsequently died from infection with the outbreak strain were initially colonised by a different candidal phenotype. In two cases this was C tropicalis. These patients did not develop systemic disease from their original endogenous yeast but became superinfected by the endemic outbreak strain, which then disseminated. The outbreak was due to a particular strain of C albicans (serotype A, morphotype Al, biotype O/,5 5/7). This strain survived better on nurses' hands than control strains of C albicans and was considerably more resistant to washing with Hibiscrub, the disinfectant mainly in use at the time of the study. The lack of an environmental source agrees with earlier work20 21 and accords with the observation that the outbreak strain did not survive better on blocks of formica than the control strains.
Of the 65 staff examined, four were oral carriers of the outbreak strain and one carried this strain on her hands. While nursing patients with systemic infections two out of 17 nurses acquired the outbreak strain. One nurse developed clinical vaginal candidosis 48 hours after nursing a patient (case 15). She had no history of the disease, and the isolate was the same as the outbreak strain. The data suggest that the cycle of infection lies between patients and staff.
In conclusion, we found that one particular strain of C albicans was capable of causing systemic candidosis as a result of cross infection between patients and staff. It not only caused invasive infections but showed a propensity to spread, possibly due to its relative resistance to washing with Hibiscrub. Previously, chemoprophylaxis has concentrated on eradicating endogenous yeast flora from the gastrointestinal tract.3 This should perhaps be combined with isolation of patients with systemic infections and heavy colonisation as well as handwashing with disinfectants that are active against candida.
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SHORT REPORTS Prolonged hypercalcaemia after industrial exposure to vitamin D3 Hypercalcaemia due to vitamin D intoxication is usually the result of a prolonged oral intake or overdosage. Individual tolerance may vary and occasionally patients may be sensitive to low doses. We report a case in which brief exposure to a process manufacturing vitamin D3 (cholecalciferol) led to prolonged intoxication and hypercalcaemia.
Case report A previously fit 32 year old laboratory technician presented on 21 April 1983 with a three week history of increasing polydipsia, anorexia, nausea, and general malaise. He had no medical history and was not taking any medication. He had helped in the crystallisation of vitamin D3 for 32 days in 1981, 11 days in 1982, and 22 days in 1983. Symptoms had started two days after he had last begun working on the manufacture of vitamin D3. There had been no other relevant exposure. A dust mask, laboratory coat, and gloves had been worn during all the procedures. Examination showed a fit, lean young man who had signs of mild dehydration. His blood pressure was 120/80 mm Hg with no postural drop and he was clinically normal.
The initial serum calcium concentration was 3-5 mmol/l (14-0 mg/100 ml) (normal 2-2-2-7 mmol/l), phosphate 1-06 mmol/l (3-3 mg/100 ml) (normal 0-8-1-45 mmol/l), alkaline phosphatase activity 154 U/I (8 KA units/l00 ml) (normal 100 U/1), and blood urea concentration 9-1 mmol/l (55 mg/100 ml) (normal 2-5-7-5 mmol/l). Serum creatinine concentration was 170 /mol/I (1-9 mg/100 ml) (normal 30-170 Mmol!l). The chest radiograph was normal and abdominal radiography showed no evidence of nephrocalcinosis. The parathyroid hormone concentration was less than 0-1 Hg/l (normal less than 0-1-0-73).
The patient was treated with intravenous saline, frusemide 40 mg eight hourly, and hydrocortisone 200 mg six hourly. His general condition improved and the calcium concentration dropped to 2-5 mmollI (10-0 mg/ 100 ml) after 10 days of treatment. He was discharged and continued with prednisolone 30 mg daily and a high fluid intake. He was readmitted a week later with a calcium concentration of 3-7 mmol/l (14-8 mg/100 ml), and despite adequate rehydration, low calcium diet, and steroids the calcium value remained high and widely fluctuant. He developed a gross Cushingoid appearance and hence the dose of hydrocortisone was gradually reduced over one week and replaced with dexamethasone, which has less tendency to cause fluid retention. Two weeks later he began cholestyramine 8 g twice daily, and over three weeks the calcium concentration fell, fluctuating between 2-5 and 2-85 mmol/l (10-0 and 11-4 mg/100 ml). After eight weeks' treatment his calcium concentrations were normal and remained so with a normal diet and no treatment (figure). After the diagnosis there was no further exposure to vitamin D.. The initial concentrations of 25-hydroxycholecalciferol one month after the exposure to vitamin D. were grossly
